FDA Accepts NDA for Vepdegestrant by Arvinas Operations
The FDA has accepted the New Drug Application (NDA) for Vepdegestrant (NDA219835) submitted by Arvinas Operations.
Asset / Drug
Drug and asset intelligence for Vepdegestrant with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
Estrogen Receptor Modulator
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.